The molecular hallmark of CML is the Philadelphia (Ph) chromosome: a reciprocal 9;22 translocation generating a fusion oncogene, BCR-ABL. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.